Sign in
4

Changes in Ownership

Cue Biopharma, Inc. Filed Acc 0001209191-19-018091

Options or other derivatives

  • CEO and President acquired 225,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
PASSERI DANIEL R CEO and President 2019-03-06 Grant or award · Stock Option (right to buy) +125,000 125,000 D
PASSERI DANIEL R CEO and President 2019-03-06 Grant or award · Stock Option (right to buy) +100,000 100,000 D
Loading xslF345X03/doc4.xml…